[1] |
KOTRONEN A,YKI-JARVINEN H.Fatty liver:a novel component of the metabolic syndrome[J].Arterioscler Thromb Vasc Biol,2008,28(1):27. |
[2] |
NOMURA K,HAMAMOTO Y,TAKAHARA S,et al.Relationship between carotid intima-media thickness and silent cerebral infarction in Japannese subjects with type 2 diabetes[J].Diabetes Care,2010,33(1):168. |
[3] |
BREA A,MOSQUREA D,MART E,et al.Nonalcoholic fatty liver disease is associated with carotid atherosclerosis:a case-control study[J].Arterioscler Thromb Vasc Biol,2005,25(5):1045. |
[4] |
VILLANOVA N,MOSCATIELLO S,RAMILLI S,et al.Endothelial dysfunction and cardiovascular risk profilr in nonalcoholic fatty liver disease[J].Hepatology,2005,42(2):473. |
[5] |
中华医学会肝脏病学分会脂肪肝和酒精肝病学组.非酒精性脂肪肝病诊疗指南[J].中华内科杂志,2010,49(3):834. |
[6] |
中国医师协会超声医师分会.血管和浅表器官超声检查指南[M].北京:人民军医出版社,2011:26. |
[7] |
范建高,曾民德.脂肪性肝病[M].北京:人民卫生出版社,2005:210. |
[8] |
POANTA LI,ALBU A,FODOR D.Association between fatty liver disease and carotid atherosclerosis in patients with uncomplicated type 2 diabetes mellitus[J].Med Ultrason,2011,13(3):215. |
[9] |
段晓燕,范建高.欧洲肝病学会非酒精性脂肪性肝病专家共识[J].肝脏,2010,15(6):451. |
[10] |
TARGHER G,BERTOLINI L,PADOVANI R,et al.Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients[J].J Endocrinol Invest,2006,29(1):55. |
[11] |
俞金莲.非酒精性脂肪肝与颈动脉粥样硬化的相关性研究[J].中国现代医生,2011,49(36):53. |
[12] |
付景成,刘朝阳.非酒精性脂肪肝与颈动脉粥样硬化的关系[J].中国实用医药,2010,5(5):94. |
[13] |
韩召展,董会文,任会远,等.氧化应激产物、炎症因子与颈动脉粥样硬化的关系探讨[J].中西医结合心脑血管病杂志,2010,8(2):244. |
[14] |
王燕,殷镜海,李会庆,等.氧化LDL抗体对颈动脉粥样硬化斑块发生影响[J].中国公共卫生,2008,25(2):179. |
[15] |
周俊山.氧化应激、微炎症反应、血流切应力和颈动脉斑块稳定性[J].神经病学与神经康复学杂志,2005,2(4):240. |